Category Archives: Food & Drug Recalls

Voluntary Recall Of Goya, Great Value, Hatuey, Mr. Special, Polar, Publix, Regal, And SuperMax Brand Malta Beverages In 7-oz Bottles Due To Possible Health Risk

The Florida Brewery, Inc. is recalling certain lots of Goya, Great Value, Hatuey, Mr. Special, Polar, Publix, Regal, and SuperMax brand non-alcoholic malta beverages packaged in 7-oz bottles because glass on the exterior of the bottles may break when the twist-off cap is removed from the bottle and can result in cuts to the mouth. To date, the Company has received two reports of consumers experiencing cuts to the mouth.

American Regent Initiates Nationwide Voluntary Recall Of Phenylephrine HCl Injection, USP, 1% 5 mL Vial, Lot# 0693 Due To Visible Particles

American Regent is conducting a nationwide voluntary recall to the Retail/Hospital level of the following product: Phenylephrine HCl Injection, USP, 1% (10mg/mL), 5 mL Vial NDC # 0517-0405-25, Lot # 0693, Exp Date: October, 2012. PLEASE NOTE: This recall, initiated on February 22, 2012 to the Retail/Hospital Level, is for Lot # 0693 only.

Healthy People Co. is Expanding its Voluntary Recall Initiated on February 02, 2012 to Include Dietary Products Bought on or Before October 25, 2011

Healthy People Co. announced today that is expanding its voluntary nationwide recall of the company’s dietary supplements sold under the brand names described below, regardless of the lot numbers referenced herein, and to the extent these products were bought on or before October 25, 2011. On February 02, 2011, Healthy People Co. conducted a voluntary recall because FDA lab analysis confirmed the presence of Sibutramine and Tadalafil in the products identified herein, making the following products unapproved new drugs:

FDA approves Korlym for patients with endogenous Cushing’s syndrome

Today, Korlym (mifepristone) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in adults with endogenous Cushing’s syndrome. This drug was approved for use in patients with endogenous Cushing’s syndrome who have type 2 diabetes or glucose intolerance and are not candidates for surgery or who have not responded to prior surgery. Korlym should never be used (contraindicated) by pregnant women.